XXXVI Congreso SETH

Ponencias 39 13. Arroyo JL, Martínez E, Amunarriz C, et al. Methylene blue-treated plasma, versus quarantine fresh frozen plasma, for acute thrombo- tic thrombocytopenic purpura treatment: Comparison between cen- tres and critical review on longitudinal data. Transfus Apher Sci 2020;59:102771. 14. Howard MA, Williams LA, Terrell DR, et al. Complications of plas- ma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2006;46:154-6. 15. Sidhu D, Snyder EL, Tormey CA. Two approaches to the clinical dilemma of treating TTP with therapeutic plasma exchange in patients with a history of anaphylactic reactions to plasma. J Clin Apher 2017;32:158-62. 16. Lim W, Vesely SK, George JN. The role of rituximab in the manage- ment of patients with acquired thrombotic thrombocytopenic purpura. Blood 2015;125:1526-31. 17. McDonald V, Manns K, Mackie IJ, et al. Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocyto- penic purpura. J Thromb Haemost 2010;8:1201-8.